You have 9 free searches left this month | for more free features.

adjuvant RT

Showing 1 - 25 of 6,458

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer, Urothelial Carcinoma Bladder Trial in Mumbai (Adjuvant RT)

Recruiting
  • Bladder Cancer
  • Urothelial Carcinoma Bladder
  • Adjuvant RT
  • Mumbai, Maharashtra, India
    Tata Memorial Centre
Oct 6, 2021

Skin Cancer, Non-Melanoma Trial (Surgery with additional moderate hypofractionation RT (15 fractions), Surgery alone, without

Not yet recruiting
  • Skin Cancer, Non-Melanoma
  • Surgery with additional moderate hypofractionation RT (15 fractions)
  • +2 more
  • (no location specified)
Mar 20, 2023

3D Specimen Maps for RT Planning

Recruiting
  • Head and Neck Cancer
  • +2 more
    • Nashville, Tennessee
      Vanderbilt Medical Center
    Feb 23, 2023

    HPV-Related Squamous Cell Carcinoma, HNSCC Trial in Chicago (drug, procedure, radiation)

    Active, not recruiting
    • HPV-Related Squamous Cell Carcinoma
    • HNSCC
    • Chicago, Illinois
      University of Chicago Medical Center
    Nov 12, 2021

    Glioblastoma Trial in Boston (radiation, biological, drug)

    Recruiting
    • Glioblastoma
    • Radiation Therapy
    • +3 more
    • Boston, Massachusetts
    • +1 more
    May 31, 2022

    Prostate Cancer Trial in Australia, New Zealand (Adjuvant Radiotherapy, Early Salvage Radiotherapy)

    Active, not recruiting
    • Prostate Cancer
    • Adjuvant Radiotherapy
    • Early Salvage Radiotherapy
    • Campbelltown, New South Wales, Australia
    • +35 more
    Nov 16, 2022

    Glioblastoma Trial in Baltimore (Concurrent CRT Period, Post-CRT Period, Adjuvant Period)

    Recruiting
    • Glioblastoma
    • Concurrent CRT Period
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University/Johns Hopkins Hospital
    Mar 2, 2023

    Breast Cancer Female Trial in Kolkata (3 week RT, 1 week RT)

    Recruiting
    • Breast Cancer Female
    • 3 week RT
    • 1 week RT
    • Kolkata, West Bengal, India
      Sanjoy Chatterjee
    Dec 2, 2021

    Squamous Cell Carcinoma of Head and Neck Trial in Nice (Cisplatin, Nivolumab, RT)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Nice, France
      Centre Antoine Lacassagne
    Mar 10, 2022

    Carcinoma, Squamous Cell of Head and Neck, Oropharynx Squamous Cell Carcinoma Trial in Atlanta, Portland, Pittsburgh (Nivolumab

    Active, not recruiting
    • Carcinoma, Squamous Cell of Head and Neck
    • Oropharynx Squamous Cell Carcinoma
    • Nivolumab Injection
    • Radiotherapy (RT)
    • Atlanta, Georgia
    • +2 more
    Mar 24, 2022

    Glioma of Brain Trial in Taoyuan (postoperative adjuvant RT)

    Recruiting
    • Glioma of Brain
    • postoperative adjuvant RT
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital
    Mar 9, 2021

    Primary Glioblastoma, Glioblastoma Multiforme Trial in Worldwide (2-OHOA, TMZ, RT)

    Recruiting
    • Primary Glioblastoma
    • Glioblastoma Multiforme
    • Angers, France
    • +19 more
    Dec 13, 2022

    Breast Cancer, Hypofractionation, Radiotherapy Side Effect Trial in Chandigarh (1 week RT, 2 week RT)

    Recruiting
    • Breast Cancer
    • +2 more
    • 1 week RT
    • 2 week RT
    • Chandigarh, India
      Budhi Singh Yadav
    Jun 22, 2021

    Cervical Carcinoma, Endometrial Carcinoma Trial in Salt Lake City (Hypofractionated Radiation Therapy)

    Recruiting
    • Cervical Carcinoma
    • Endometrial Carcinoma
    • Hypofractionated Radiation Therapy
    • Salt Lake City, Utah
      Huntsman Cancer Institute/University of Utah
    Mar 1, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in Strasbourg (Split Cisplatin, Cisplatin, Radiotherapy)

    Completed
    • Squamous Cell Carcinoma of the Head and Neck
    • Split Cisplatin
    • +2 more
    • Strasbourg, France
      Centre Paul Strauss
    Mar 10, 2022

    Pleural Malignant Mesothelioma Trial in Houston (other, radiation, biological)

    Recruiting
    • Pleural Malignant Mesothelioma
    • Laboratory Biomarker Analysis
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 13, 2022

    Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (Nimotuzumab, Placebo)

    Active, not recruiting
    • Carcinoma, Squamous Cell of Head and Neck
    • Bedford Park, Australia
    • +29 more
    Apr 4, 2022

    Lymphedema, Fibrosis Trial in Aarhus (Loco-regional RT)

    Active, not recruiting
    • Lymphedema
    • Fibrosis
    • Loco-regional RT
    • Aarhus, Denmark
      Aarhus University Hospital
    Jul 7, 2021

    Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)

    Active, not recruiting
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • IMRT
    • Nivolumab
    • Atlanta, Georgia
    • +3 more
    Jan 10, 2023

    Whether Changing Sequence of Treatments is Feasible

    Recruiting
    • Breast Cancer
    • Intensity modulated radiotherapy (IMRT)
    • +2 more
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust
    Jul 26, 2021

    Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

    Recruiting
    • Glioblastoma
    • Gliosarcoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2022

    Breast Tumor Female, Complication of Radiation Therapy, Breast Implant; Complications Trial in Denmark (Delayed-immediate

    Recruiting
    • Breast Neoplasm Female
    • +2 more
    • Delayed-immediate reconstruction
    • Delayed reconstruction
    • Aalborg, Denmark
    • +6 more
    Aug 17, 2021

    Breast Cancer Trial in New York (Carboplatin, 3D-RT or IMRT)

    Completed
    • Breast Cancer
    • New York, New York
      NYU Cancer Center
    Dec 16, 2020

    Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)

    Not yet recruiting
    • Gastrooesophageal Cancer
    • Trastuzumab deruxtecan
    • Southampton, Hampshire, United Kingdom
    • +16 more
    Jul 27, 2023

    Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

    Recruiting
    • Glioblastoma, IDH-wildtype
    • MGMT-Methylated Glioblastoma
    • Padova, Italy
      Istituto Oncologico Veneto IRCCS
    Oct 18, 2023